These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 272928)

  • 1. Treatment of chronic granulocytic leukemia with melphalan.
    Hauch T; Logue G; Laszlo J; Cox E; Rundles W
    Blood; 1978 Apr; 51(4):571-7. PubMed ID: 272928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic granulocytic leukemia after renal transplantation.
    Kirchner KA; Files JC; Didlake R; Raju S; Krueger RP
    Arch Intern Med; 1983 Oct; 143(10):1984-7. PubMed ID: 6354125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
    Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J
    Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic granulocytic leukemia without the Philadelphia chromosome.
    Canellos GP; Whang-Peng J; DeVita VT
    Am J Clin Pathol; 1976 Apr; 65(4):467-70. PubMed ID: 1063540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission.
    Tiedemann K; Waters KD; Tauro GP; Tucker D; Ekert H
    Blood; 1993 Dec; 82(12):3730-8. PubMed ID: 8260710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Very long survivals of chronic granulocytic leukemia (author's transl)].
    Debray J; Pommier Y; Audebert AA; Krulik M; Smadja N; Zylberait D
    Sem Hop; 1980 Feb 18-25; 56(7-8):309-13. PubMed ID: 6246623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Econometric analysis of phase duration for blood morphology and basophil count alterations in chronic granulocytic leukaemia.
    Gola A; Smakowska E; Waszkiewicz L; Błaczkowska A; Kin-Dittmann I; Zielińska K; Czajkowska B; Pajsert E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):271-5. PubMed ID: 6205949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myelosis with osteolytic changes favourably influenced by alkeran.
    Krause J; Průsa P
    Neoplasma; 1970; 17(3):317-20. PubMed ID: 5270282
    [No Abstract]   [Full Text] [Related]  

  • 9. Additive pulmonary toxicity with melphalan and busulfan therapy.
    Schallier D; Impens N; Warson F; Van Belle S; De Wasch G
    Chest; 1983 Oct; 84(4):492-3. PubMed ID: 6578007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningeal leukemia in the blastic phase of chronic granulocytic leukemia.
    Schwartz JH; Canellos GP; Young RC; DeVita VT
    Am J Med; 1975 Dec; 59(6):819-28. PubMed ID: 1059328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I-II trial of VP-16 in the treatment of acute nonlymphocytic leukemia and blast crisis of chronic granulocytic leukemia.
    Mailliard JA; Letendre L; Dalton RJ; Levitt R; Gerstner JB; Therneau TM; Pierre RV
    Med Pediatr Oncol; 1986; 14(6):306-9. PubMed ID: 3466001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan.
    Canellos GP; Young RC; Neiman PE; DeVita VT
    Blood; 1975 Feb; 45(2):197-203. PubMed ID: 1054609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea and 6-mercaptopurine in the treatment of chronic granulocytic leukemia.
    Lazzarino M; Morra E; Brusamolino E; Inverardi D; Castelli G; Merante S; Bernasconi C
    Am J Clin Oncol; 1986 Feb; 9(1):45-9. PubMed ID: 3513537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy.
    Canellos GP; DeVita VT; Whang-Peng J; Chabner BA; Schein PS; Young RC
    Blood; 1976 Jun; 47(6):1003-9. PubMed ID: 1064434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Ph1-negative marrow cells in Ph1-positive chronic granulocytic leukemia.
    Sokal JE
    Blood; 1980 Dec; 56(6):1072-6. PubMed ID: 6934013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations of chronic granulocytic leukemia.
    Spiers AS
    Semin Oncol; 1995 Aug; 22(4):380-95. PubMed ID: 7638635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pluripotent, erythrocytic and granulocytic hemopoietic precursors in chronic granulocytic leukemia.
    Hara H; Kai S; Fushimi M; Taniwaki S; Ifuku H; Okamoto T; Ohe Y; Fujita S; Noguchi K; Kanamaru A; Nagai K; Inada E
    Exp Hematol; 1981 Sep; 9(8):871-7. PubMed ID: 6948685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and toxicity of low-dose melphalan in myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia.
    Robak T; Szmigielska-Kapłon A; Urbańska-Ryś H; Chojnowski K; Wrzesień-Kuś A
    Neoplasma; 2003; 50(3):172-5. PubMed ID: 12937849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic granulocytic leukemia (CGL) during the course of chronic lymphocytic leukemia (CLL): correlation of blood, marrow, and spleen morphology and cytogenetics.
    Whang-Peng J; Gralnick HR; Johnson RE; Lee EC; Lear A
    Blood; 1974 Mar; 43(3):333-9. PubMed ID: 4521368
    [No Abstract]   [Full Text] [Related]  

  • 20. Smoldering acute granulocytic leukemia. Observations on its natural history and morphologic characteristics.
    Van Slyck EJ; Rebuck JW; Waddell CC; Janakiraman N
    Arch Intern Med; 1983 Jan; 143(1):37-40. PubMed ID: 6571780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.